Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Change in Accured Expenses (2020 - 2025)

Historic Change in Accured Expenses for Cellebrite DI (CLBT) over the last 6 years, with Q4 2025 value amounting to $6.8 million.

  • Cellebrite DI's Change in Accured Expenses fell 4190.41% to $6.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $24.0 million, marking a year-over-year increase of 3648.36%. This contributed to the annual value of $4.2 million for FY2025, which is 7584.44% down from last year.
  • Cellebrite DI's Change in Accured Expenses amounted to $6.8 million in Q4 2025, which was down 4190.41% from $17.6 million recorded in Q2 2025.
  • In the past 5 years, Cellebrite DI's Change in Accured Expenses ranged from a high of $17.6 million in Q2 2025 and a low of -$12.2 million during Q1 2025
  • Its 5-year average for Change in Accured Expenses is $1.4 million, with a median of $2.4 million in 2021.
  • In the last 5 years, Cellebrite DI's Change in Accured Expenses plummeted by 18484.35% in 2022 and then soared by 80928.07% in 2024.
  • Cellebrite DI's Change in Accured Expenses (Quarter) stood at $2.4 million in 2021, then tumbled by 184.84% to -$2.1 million in 2022, then soared by 370.44% to $5.6 million in 2023, then soared by 110.41% to $11.7 million in 2024, then plummeted by 41.9% to $6.8 million in 2025.
  • Its Change in Accured Expenses was $6.8 million in Q4 2025, compared to $17.6 million in Q2 2025 and -$12.2 million in Q1 2025.